Results 141 to 150 of about 169,328 (165)
Some of the next articles are maybe not open access.
Pamrevlumab did not meet its primary endpoint for non-ambulatory patients with Duchenne Muscular Dystrophy: the LELANTOS-1 trial
medRxivA. M. Connolly, B. L. Wong, H. Phan, E. Mercuri, X. Cai, C. Tian, S. De Lucia, S. F. Nelson, Y. Péréon, S. Previtali, S. Wang, O. V. Gambetti, J. Brandsema, E. Carrier, on behalf of the LELANTOS-1 study investigators +14 moresemanticscholar +1 more sourceEarly diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations
Expert Review of Clinical Immunology, 2016 P. Brito-Zerón, E. Theander, C. Baldini, R. Seror, S. Retamozo, L. Quartuccio, H. Bootsma, S. Bowman, T. Dörner, J. Gottenberg, X. Mariette, S. Bombardieri, S. De Vita, T. Mandl, W. Ng, A. Kruize, A. Tzioufas, C. Vitali, J. Buyon, P. Izmirly, R. Fox, M. Ramos-Casals, on behalf of the EULAR Sjögren Syndrome Task Force +22 moresemanticscholar +1 more sourceFourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder
Archives of Women's Mental Health, 2016 E. Ismaili, Sally Walsh, P. O'brien, T. Bäckström, Candace S. Brown, L. Dennerstein, E. Eriksson, E. Freeman, K. Ismail, N. Panay, T. Pearlstein, A. Rapkin, M. Steiner, J. Studd, Inger Sundström-Paromma, J. Endicott, C. N. Epperson, U. Halbreich, R. Reid, D. Rubinow, P. Schmidt, K. Yonkers, Consensus Group of the International Society for Premenstrua Disorders +22 moresemanticscholar +1 more source
